Molina Healthcare, Inc.: Form 10-Q for the period ended Jun 30, 2024
Filed with the SEC on Jul 25, 2024 and accepted by EDGAR at Jul 25, 2024, 11:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-04-01 to 2024-06-30 | $9.88bn | us-gaap:Revenues |
| Revenue | 6 months2024-01-01 to 2024-06-30 | $19.81bn | us-gaap:Revenues |
| Cost of revenue | 3 months2024-04-01 to 2024-06-30 | $8.37bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2024-01-01 to 2024-06-30 | $16.78bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2024-04-01 to 2024-06-30 | $434.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-01-01 to 2024-06-30 | $860.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-04-01 to 2024-06-30 | $28.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2024-01-01 to 2024-06-30 | $55.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2024-04-01 to 2024-06-30 | $105.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-01-01 to 2024-06-30 | $203.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-04-01 to 2024-06-30 | $301.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-01-01 to 2024-06-30 | $602.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-04-01 to 2024-06-30 | $5.17 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-01-01 to 2024-06-30 | $10.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-04-01 to 2024-06-30 | $5.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-01-01 to 2024-06-30 | $10.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-04-01 to 2024-06-30 | 58,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-01-01 to 2024-06-30 | 58,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-01-01 to 2024-06-30 | −$5.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-01-01 to 2024-06-30 | $54.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-06-30 | $4.35bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-06-30 | $12.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-06-30 | $15.19bn | us-gaap:Assets |
| Current liabilities | At period end2024-06-30 | $7.84bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-06-30 | $10.34bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-06-30 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-06-30 | $4.84bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001179929-24-000123. Last ingested by Listed: Nov 6, 2026, 17:05 ET. Listed shows no prices and gives no investment advice.